EP
CHE icon

Essential Partners’s Chemed CHE Stock Holding History

Essential Partners’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Buy
609
+450
+283% +$189K 0.13% 170
2026
Q1 		$60.1K Sell
159
-305
-66% -$131K 0.02% 557
2025
Q4 		$199K Buy
464
+104
+29% +$45.3K 0.06% 318
2025
Q3 		$161K Buy
360
+289
+407% +$131K 0.05% 358
2025
Q2 		$34.6K Buy
+71
New +$40.5K 0.01% 550

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Essential Partners's CHE Position: Q2 2026 in Review

Essential Partners increased its Chemed (CHE) stake by 283% in Q2 2026, buying an estimated $189K and bringing the position to 609 shares worth $284K. The position accounts for 0.13% of the portfolio, ranked #170.

Essential Partners first reported a position in CHE in Q2 2025 and has held it in 5 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Essential Partners held 609 shares of Chemed worth $284K as of Q2 2026.
  • Essential Partners bought 450 Chemed shares in Q2 2026, an estimated $189K.
  • Chemed made up 0.13% of Essential Partners's portfolio in Q2 2026, its #170 holding.
  • Essential Partners first reported a position in Chemed in Q2 2025 and has held it in 5 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.